Baomin Shi

494 total citations · 1 hit paper
14 papers, 379 citations indexed

About

Baomin Shi is a scholar working on Surgery, Molecular Biology and Hepatology. According to data from OpenAlex, Baomin Shi has authored 14 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Molecular Biology and 4 papers in Hepatology. Recurrent topics in Baomin Shi's work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Liver physiology and pathology (2 papers) and Gastrointestinal disorders and treatments (2 papers). Baomin Shi is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Liver physiology and pathology (2 papers) and Gastrointestinal disorders and treatments (2 papers). Baomin Shi collaborates with scholars based in China, United States and India. Baomin Shi's co-authors include Zhongyan Liu, Yufeng Wang, Nanbin Liu, Kun Li, Ran Qi, Hui Wang, Rui Lin, Xinbo Li, Yixuan Bai and Xiuyan Wang and has published in prestigious journals such as World Journal of Gastroenterology, Cell Death and Disease and Frontiers in Pharmacology.

In The Last Decade

Baomin Shi

13 papers receiving 377 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs

2023 190 citations Ran Qi, Yixuan Bai et al. Drug Resistance Updates profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Baomin Shi China	9	218	149	90	87	39	14	379
Yong Mou China	12	261 1.2×	169 1.1×	201 2.2×	40 0.5×	27 0.7×	22	513
Taolang Li China	13	240 1.1×	111 0.7×	93 1.0×	67 0.8×	79 2.0×	47	420
Feng Cao China	13	200 0.9×	151 1.0×	75 0.8×	62 0.7×	82 2.1×	33	385
Shigeto Nishikawa Japan	10	171 0.8×	96 0.6×	78 0.9×	112 1.3×	53 1.4×	31	353
Kisha Mitchell-Richards United States	8	126 0.6×	45 0.3×	61 0.7×	62 0.7×	108 2.8×	13	343
Ibone Labiano Spain	7	289 1.3×	108 0.7×	41 0.5×	84 1.0×	91 2.3×	10	493
Dongdong Zhou China	12	210 1.0×	146 1.0×	46 0.5×	99 1.1×	19 0.5×	29	389
Wanfeng Zhang China	13	257 1.2×	171 1.1×	87 1.0×	50 0.6×	34 0.9×	30	371
Surbhi Chouhan United States	9	168 0.8×	103 0.7×	52 0.6×	90 1.0×	35 0.9×	13	315
Yan Dai China	10	182 0.8×	84 0.6×	46 0.5×	124 1.4×	52 1.3×	19	421

Countries citing papers authored by Baomin Shi

Since Specialization

Citations

This map shows the geographic impact of Baomin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baomin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baomin Shi more than expected).

Fields of papers citing papers by Baomin Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baomin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baomin Shi. The network helps show where Baomin Shi may publish in the future.

Co-authorship network of co-authors of Baomin Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Baomin Shi. A scholar is included among the top collaborators of Baomin Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baomin Shi. Baomin Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Li, Kun, et al.. (2024). Adenocarcinoma developing from gastric heterotopic pancreas: a case report and short review. Frontiers in Surgery. 11. 1274389–1274389.

Qi, Ran, Yixuan Bai, Kun Li, et al.. (2023). Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs. Drug Resistance Updates. 68. 100960–100960. 190 indexed citations breakdown →

Zhang, Gong, Bryan C. Fuchs, Wei Guo, et al.. (2022). Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram. Frontiers in Oncology. 12. 913736–913736. 14 indexed citations

Wei, Yuhua, Yufeng Wang, Nanbin Liu, et al.. (2022). A FAK Inhibitor Boosts Anti-PD1 Immunotherapy in a Hepatocellular Carcinoma Mouse Model. Frontiers in Pharmacology. 12. 820446–820446. 21 indexed citations

Lin, Rui, Xunxia Bao, Hui Wang, et al.. (2021). TRPM2 promotes pancreatic cancer by PKC/MAPK pathway. Cell Death and Disease. 12(6). 585–585. 54 indexed citations

Li, Kun, et al.. (2021). Asymptomatic gastric adenomyoma and heterotopic pancreas in a patient with pancreatic cancer: A case report and review of the literature. World Journal of Clinical Cases. 9(27). 8147–8156. 3 indexed citations

Chen, Quanning, et al.. (2020). Synchronous hepatocellular carcinoma and gallbladder adenocarcinoma with neuroendocrine differentiation: a case report and literature review. BMC Surgery. 20(1). 246–246. 4 indexed citations

Wang, Xiuyan, Jiang Tian, Shuo Wang, et al.. (2019). Value of early diagnosis of sepsis complicated with acute kidney injury by renal contrast-enhanced ultrasound. World Journal of Clinical Cases. 7(23). 3934–3944. 10 indexed citations

Lin, Rui, Yufeng Wang, Quanning Chen, et al.. (2018). TRPM2 promotes the proliferation and invasion of pancreatic ductal adenocarcinoma. Molecular Medicine Reports. 17(6). 7537–7544. 31 indexed citations

10.

Wang, Feng, et al.. (2018). Roles and mechanisms of action of HNF‑4α in�the�hepatic differentiation of WB‑F344 cells. International Journal of Molecular Medicine. 43(2). 1021–1032. 2 indexed citations

11.

Xue, Ying, et al.. (2016). Serum Calcium and Risk of Nonmedullary Thyroid Cancer in Patients with Primary Hyperparathyroidism. Medical Science Monitor. 22. 4482–4489. 9 indexed citations

12.

Ge, Lan, et al.. (2015). Clinical value of real-time elastography quantitative parameters in evaluating the stage of liver fibrosis and cirrhosis. Experimental and Therapeutic Medicine. 10(3). 983–990. 16 indexed citations

13.

Shi, Baomin, et al.. (2013). Functional Modules Analysis Based on Coexpression Network in Pancreatic Ductal Adenocarcinoma. Pathology & Oncology Research. 20(2). 293–299. 5 indexed citations

14.

Xu, Hao, Baomin Shi, Xiaofei Lü, et al.. (2008). Vascular endothelial growth factor attenuates hepatic sinusoidal capillarization in thioacetamide-induced cirrhotic rats. World Journal of Gastroenterology. 14(15). 2349–2349. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact